Webinar Date/Time: Wednesday, May 29th 11am EDT | 4pm GMT | 5pm CEST
Join us for this webinar focused on the development of continuous tableting processes.
Register Free: https://www.pharmtech.com/pt_w/continuous-tableting
Event Overview:
Upcoming Sessions:
Session 2: June 20th: “Insights from Commercial Implementation of Continuous Tableting: Successes and Challenges of a Partnership-Oriented Approach”
Session 3: July 10th: “Simplification of Continuous Tableting for Accelerated Product Development and Lifecycle Flexibility”First Session Overiview:
Series Overview
This comprehensive webinar series, focused on continuous manufacturing of oral solid dosage forms, also known as continuous tableting (CT), aims to highlight key opportunities, successes and challenges with continuous tableting. Content of the webinars will cover the role of CM along a wide breadth of the CMC journey, starting with lean and model-based development and concluding with commercial implementation of continuous tableting processes. Each webinar in the series will be presented as a joint talk with participants from innovators, like Merck and Vertex Pharmaceuticals, and Hovione highlighting experiences from each organization and the many advantages of a partnership-based approach. Featured experts will be available to answer audience questions during a live Q&A that will follow each talk.
The webinar series will conclude with a final presentation, shared as a joint talk between GEA and Hovione announcing exciting joint innovations in the CT equipment space along with the latest advances in technology simplification.
First Session Overview:
The first webinar of the series focuses on the development of continuous tableting processes. The webinar, presented as a collaborative talk, shares institutional experience on lean development methodologies, specifically, how a hybrid approach results in development of robust processes while minimizing the use of the active pharmaceutical ingredient (API) and time on the integrated process. The webinar will discuss in detail how carefully curated experiments inform process models, which in turn inform process performance. Success and challenges associated with this approach will be shared via means of case studies focused on loss-in-weight feeders. This webinar will be co-presented by speakers from Hovione and Merck Sharpe and Dohme.
Key Learnings for the Webinar Series:
Who Should Attend:
Speakers:
João Henriques
R&D Director, Oral Drug Product Development
Hovione
João Henriques, MSc, is the director of oral drug product development at Hovione R&D, specializing in formulation, particle engineering, and process development of pharmaceutical drug products for oral delivery. With a degree in Biological Engineering from the U. Lisbon, Portugal, João started his professional career in biopharma before joining Hovione in 2008. There, he has worked within Operational Excellence and Process Analytical Technologies groups before starting as a scientist in the Drug Product Development group at R&D, where he gained extensive experience in spray drying and drug product formulations and processes.
James Tarabokija
Scientist, Oral Formulation Sciences
Merck Sharpe & Dohme
James Tarabokija is a scientist in Oral Formulation Sciences at Merck Sharpe & Dohme, specializing in continuous manufacturing formulation and process development. He is responsible for material sparing lab tests and pilot scale assessments to determine the feasibility of continuous manufacturing for new pipeline assets. James holds a bachelor’s degree in chemical engineering and a master’s degree in pharmaceutical engineering from the New Jersey Institute of Technology.
Register Free: https://www.pharmtech.com/pt_w/continuous-tableting
Exosomes Field Advances with Milestones Achieved by EXO Biologics and ExoXpert
December 4th 2024EXO Biologics and ExoXpert, an EXO Biologics subsidiary, have received GMP certification of a European manufacturing facility for exosomes and have successfully loaded mRNA and DNA payloads into GMP-grade exosomes for drug delivery.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development
March 26th 2024In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.